{
    "eid": "2-s2.0-85088146256",
    "title": "Successful challenge of voriconazole in a patient with posaconazole-associated minor drug eruption: A case report",
    "cover-date": "2020-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "antifungals",
        "cross-reactivity",
        "hypersensitivity",
        "maculopapular rash",
        "posaconazole",
        "triazole",
        "voriconazole"
    ],
    "authors": [
        "Benjabhorn Weeraphon",
        "Jakapat Vanichanan",
        "Sang Usayaporn"
    ],
    "citedby-count": 1,
    "ref-count": 14,
    "ref-list": [
        "Pharmacokinetics, safety and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection",
        "Pharmacokinetics of different dosing strategies of oral posaconazole in patients with compromised gastrointestinal function and who are at high risk for invasive fungal infection",
        "European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia",
        "Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology",
        "Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Disease Society of America",
        "Posaconazole: an update of its clinical use",
        "Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease",
        "Skin allergy to Azole antifungal agents for systemic use: a review of the literature",
        "Cross-reactivity between voriconazole, fluconazole and itraconazole",
        "Lack of allergic cross-reactivity between fluconazole and voriconazole",
        "Posaconazole substitution for voriconazole-associated phototoxic effects",
        "Triazole drug allergy: successful toleration of posaconazole after reactions to fluconazole and isavuconazole"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chonburi",
            "@id": "60009116",
            "affilname": "Burapha University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009116",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "120195070",
            "affilname": "Pharmacy Council",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/120195070",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}